Cleared Traditional

K193051 - LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control Set (FDA 510(k) Clearance)

Jan 2020
Decision
89d
Days
Class 2
Risk

K193051 is an FDA 510(k) clearance for the LIAISON Lyme Total Antibody Plus, LIAISON Lyme Total Antibody Plus Control Set. This device is classified as a Reagent, Borrelia Serological Reagent (Class II - Special Controls, product code LSR).

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on January 29, 2020, 89 days after receiving the submission on November 1, 2019.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3830.

Submission Details

510(k) Number K193051 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2019
Decision Date January 29, 2020
Days to Decision 89 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LSR — Reagent, Borrelia Serological Reagent
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3830